Literature DB >> 16534460

Visual function in patients with choroidal neovascularization resulting from age-related macular degeneration: the importance of looking beyond visual acuity.

Donald C Fletcher1, Ronald A Schuchard.   

Abstract

PURPOSE: A detailed understanding of overall quality of vision may help primary care physicians, optometrists, and general ophthalmologists to improve the care of patients with choroidal neovascularization (CNV) resulting from age-related macular degeneration (AMD).
METHODS: Published literature was reviewed using Medline searches and the authors' knowledge of the field.
RESULTS: Both visual acuity and contrast sensitivity are strongly associated with the ability to perform vision-related activities of daily living. CNV resulting from AMD often leads to scotoma, which is also strongly associated with the ability to perform everyday activities such as reading and driving. Contrast sensitivity and visual field extent may be better predictors of many abilities than visual acuity. Laser photocoagulation, verteporfin therapy, and pegaptanib sodium have been proven to reduce the risk of visual acuity loss in patients with CNV resulting from AMD. Laser photocoagulation frequently causes scotoma, but data on its effects on other aspects of overall quality of vision are scarce. Verteporfin therapy has been shown to also reduce the risk of contrast sensitivity loss and has been associated with stabilization or reduction of scotoma size. Treatment effects beyond visual acuity have not been investigated for pegaptanib. Detailed assessment of overall quality of vision also aids the design of vision rehabilitation programs tailored to the needs of individual patients.
CONCLUSIONS: Understanding the impact of vision loss on patients with CNV resulting from AMD and assessing treatment benefits requires assessment of overall quality of vision. Primary care physicians and optometrists have an important role in ensuring that patients receive the best possible care, which can be aided by prompt referral to an ophthalmologist or retina specialist and collaboration with low-vision specialists and optometrists who together can make detailed assessments of overall quality of vision, implement appropriate treatment, and design effective rehabilitation strategies.

Entities:  

Mesh:

Year:  2006        PMID: 16534460     DOI: 10.1097/01.opx.0000204510.08026.7f

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  22 in total

1.  The accuracy of home monitoring to detect disease activity during maintenance therapy for neovascular ARMD.

Authors:  Martin McKibbin; Lucy Baker; Paul Baxter; Carolyn Czoski-Muray; Roopa Setty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-05       Impact factor: 3.117

2.  Non-standard vision measures predict mortality in elders: the Smith-Kettlewell Institute (SKI) study.

Authors:  Lori A Lott; Marilyn E Schneck; Gunilla Haegerström-Portnoy; John A Brabyn
Journal:  Ophthalmic Epidemiol       Date:  2010-08       Impact factor: 1.648

3.  Age related macular degeneration.

Authors:  Usha Chakravarthy
Journal:  BMJ       Date:  2006-10-28

4.  Rapid and reliable assessment of the contrast sensitivity function on an iPad.

Authors:  Michael Dorr; Luis A Lesmes; Zhong-Lin Lu; Peter J Bex
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-05       Impact factor: 4.799

5.  Effect of cataract surgery in patients with neovascular age-related macular degeneration: further evidence from disciform scars.

Authors:  Mücella Arıkan Yorgun; Yasin Toklu; Meltem Ece Kar; Basri Hasan Çakmak
Journal:  Int Ophthalmol       Date:  2017-03-02       Impact factor: 2.031

6.  Monocular and binocular smooth pursuit in central field loss.

Authors:  Natela Shanidze; Stephen Heinen; Preeti Verghese
Journal:  Vision Res       Date:  2017-01-09       Impact factor: 1.886

7.  Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration.

Authors:  R Mathew; S Sivaprasad
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

8.  Fixation stability and scotoma mapping for patients with low vision.

Authors:  Ann E Elsner; Benno L Petrig; Joel A Papay; Elli J Kollbaum; Christopher A Clark; Matthew S Muller
Journal:  Optom Vis Sci       Date:  2013-02       Impact factor: 1.973

9.  Visual function assessment in simulated real-life situations in patients with age-related macular degeneration compared to normal subjects.

Authors:  G Barteselli; M L Gomez; A L Doede; J Chhablani; W Gutstein; D-U Bartsch; L Dustin; S P Azen; W R Freeman
Journal:  Eye (Lond)       Date:  2014-08-01       Impact factor: 3.775

10.  Quality of Life with Macular Degeneration Is Not as Dark as It May Seem: Patients' Perceptions of the MacDQoL Questionnaire.

Authors:  Lisa M Ord; JoAnne Wright; Margaret M DeAngelis; Michael Feehan
Journal:  J Clin Med       Date:  2015-09-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.